141 related articles for article (PubMed ID: 7889204)
1. Nonpeptide angiotensin II type 1 receptor antagonist prevents nephrosclerosis in hypertensive rats.
Kanno Y; Okada H; Suzuki H; Ikenaga H; Saruta T
Blood Press Suppl; 1994; 5():67-70. PubMed ID: 7889204
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
Kagoshima T; Masuda J; Sutani T; Sakaguchi Y; Tsuchihashi M; Tsuruta S; Iwano M; Dohi K; Nakamura Y; Konishi N
Blood Press Suppl; 1994; 5():89-93. PubMed ID: 7889210
[TBL] [Abstract][Full Text] [Related]
3. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
Okada H; Suzuki H; Kanno Y; Ikenaga H; Saruta T
J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
[TBL] [Abstract][Full Text] [Related]
4. Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp).
Nakamura T; Honma H; Ikeda Y; Kuroyanagi R; Takano H; Obata J; Sato T; Kimura H; Yoshida Y; Tamura K
Blood Press Suppl; 1994; 5():61-6. PubMed ID: 7889203
[TBL] [Abstract][Full Text] [Related]
5. TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats.
Shibouta Y; Chatani F; Ishimura Y; Sanada T; Ohta M; Inada Y; Nishikawa K
Kidney Int Suppl; 1996 Jun; 55():S115-8. PubMed ID: 8743529
[TBL] [Abstract][Full Text] [Related]
6. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
[TBL] [Abstract][Full Text] [Related]
7. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
[TBL] [Abstract][Full Text] [Related]
8. Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis.
Nakaya H; Sasamura H; Hayashi M; Saruta T
J Am Soc Nephrol; 2001 Apr; 12(4):659-666. PubMed ID: 11274226
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
[TBL] [Abstract][Full Text] [Related]
10. TCV 116 prevents progressive renal injury in rats with extensive renal mass ablation.
Mackenzie HS; Troy JL; Rennke HG; Brenner BM
J Hypertens Suppl; 1994 Nov; 12(9):S11-6. PubMed ID: 7884578
[TBL] [Abstract][Full Text] [Related]
11. [Effects of antihypertensive therapy on the renal function in spontaneously hypertensive rats (SHR) with renal ablation].
Kanazawa M; Abe K; Yasujima M; Yoshida K; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):33-44. PubMed ID: 2348572
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116.
Nishikawa K; Inada Y; Shibouta Y; Wada T; Ojima M; Kubo K; Naka T
Blood Press Suppl; 1994; 5():7-14. PubMed ID: 7889205
[TBL] [Abstract][Full Text] [Related]
13. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
[TBL] [Abstract][Full Text] [Related]
14. Glomerular dimensions in spontaneously hypertensive rats: effects of AT1 antagonism.
Kett MM; Alcorn D; Bertram JF; Anderson WP
J Hypertens; 1996 Jan; 14(1):107-13. PubMed ID: 12013482
[TBL] [Abstract][Full Text] [Related]
15. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
[TBL] [Abstract][Full Text] [Related]
16. Effect of an angiotensin II receptor antagonist, TCV-116, on rat carotid artery neointimal formation after balloon injury.
Kino H; Hama J; Takenaka T; Sugimura K; Kamoi K; Shimada S; Yamamoto Y; Nagata S; Horiuchi M; Katori R
Blood Press Suppl; 1994; 5():43-8. PubMed ID: 7889200
[TBL] [Abstract][Full Text] [Related]
17. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
Inada Y; Wada T; Shibouta Y; Ojima M; Sanada T; Ohtsuki K; Itoh K; Kubo K; Kohara Y; Naka T
J Pharmacol Exp Ther; 1994 Mar; 268(3):1540-7. PubMed ID: 8138966
[TBL] [Abstract][Full Text] [Related]
19. Renal responses of the nonclipped kidney of two-kidney/one-clip Goldblatt hypertensive rats to type 1 angiotensin II receptor blockade with candesartan.
Cervenka L; Navar LG
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S197-201. PubMed ID: 9892163
[TBL] [Abstract][Full Text] [Related]
20. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
